A standard set of value-based patient-centered outcomes for breast cancer: The International Consortium for Health Outcomes Measurement (ICHOM) initiative

Wee Loon Ong, Maartje G. Schouwenburg, Annelotte C M Van Bommel, Caleb Stowell, Kim H. Allison, Karen E. Benn, John P. Browne, Rodney D. Cooter, Geoff P. Delaney, Francois P. Duhoux, Patricia A. Ganz, Patricia Hancock, Reshma Jagsi, Felicia M. Knaul, Anne M. Knip, Linetta B. Koppert, Henry M. Kuerer, Sarah McLaughin, Marc A.M. Mureau, Ann H. Partridge

Research output: Contribution to journalArticleOtherpeer-review

Abstract

A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The working group convened via 8 teleconferences and completed a follow-up survey after each meeting. A modified 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be included. Patient focus group meetings (8 early or metastatic BC patients) and online anonymized surveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input. The standard set encompasses survival and cancer control, and disutility of care (eg, acute treatment complications) outcomes, to be collected through administrative data and/or clinical records. A combination of multiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree of health outcomes. Selected case-mix factors were recommended to be collected at baseline. The ICHOM will endeavor to achieve wide buy-in of this set and facilitate its implementation in routine clinical practice in various settings and institutions worldwide.

Original languageEnglish
Pages (from-to)677-685
Number of pages9
JournalJAMA Oncology
Volume3
Issue number5
DOIs
Publication statusPublished - 2017

Cite this

Ong, Wee Loon ; Schouwenburg, Maartje G. ; Van Bommel, Annelotte C M ; Stowell, Caleb ; Allison, Kim H. ; Benn, Karen E. ; Browne, John P. ; Cooter, Rodney D. ; Delaney, Geoff P. ; Duhoux, Francois P. ; Ganz, Patricia A. ; Hancock, Patricia ; Jagsi, Reshma ; Knaul, Felicia M. ; Knip, Anne M. ; Koppert, Linetta B. ; Kuerer, Henry M. ; McLaughin, Sarah ; Mureau, Marc A.M. ; Partridge, Ann H. / A standard set of value-based patient-centered outcomes for breast cancer : The International Consortium for Health Outcomes Measurement (ICHOM) initiative. In: JAMA Oncology. 2017 ; Vol. 3, No. 5. pp. 677-685.
@article{5ff3da1fdf734824b8fa88b9bcc562f8,
title = "A standard set of value-based patient-centered outcomes for breast cancer: The International Consortium for Health Outcomes Measurement (ICHOM) initiative",
abstract = "A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The working group convened via 8 teleconferences and completed a follow-up survey after each meeting. A modified 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be included. Patient focus group meetings (8 early or metastatic BC patients) and online anonymized surveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input. The standard set encompasses survival and cancer control, and disutility of care (eg, acute treatment complications) outcomes, to be collected through administrative data and/or clinical records. A combination of multiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree of health outcomes. Selected case-mix factors were recommended to be collected at baseline. The ICHOM will endeavor to achieve wide buy-in of this set and facilitate its implementation in routine clinical practice in various settings and institutions worldwide.",
author = "Ong, {Wee Loon} and Schouwenburg, {Maartje G.} and {Van Bommel}, {Annelotte C M} and Caleb Stowell and Allison, {Kim H.} and Benn, {Karen E.} and Browne, {John P.} and Cooter, {Rodney D.} and Delaney, {Geoff P.} and Duhoux, {Francois P.} and Ganz, {Patricia A.} and Patricia Hancock and Reshma Jagsi and Knaul, {Felicia M.} and Knip, {Anne M.} and Koppert, {Linetta B.} and Kuerer, {Henry M.} and Sarah McLaughin and Mureau, {Marc A.M.} and Partridge, {Ann H.}",
year = "2017",
doi = "10.1001/jamaoncol.2016.4851",
language = "English",
volume = "3",
pages = "677--685",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association (AMA)",
number = "5",

}

Ong, WL, Schouwenburg, MG, Van Bommel, ACM, Stowell, C, Allison, KH, Benn, KE, Browne, JP, Cooter, RD, Delaney, GP, Duhoux, FP, Ganz, PA, Hancock, P, Jagsi, R, Knaul, FM, Knip, AM, Koppert, LB, Kuerer, HM, McLaughin, S, Mureau, MAM & Partridge, AH 2017, 'A standard set of value-based patient-centered outcomes for breast cancer: The International Consortium for Health Outcomes Measurement (ICHOM) initiative' JAMA Oncology, vol. 3, no. 5, pp. 677-685. https://doi.org/10.1001/jamaoncol.2016.4851

A standard set of value-based patient-centered outcomes for breast cancer : The International Consortium for Health Outcomes Measurement (ICHOM) initiative. / Ong, Wee Loon; Schouwenburg, Maartje G.; Van Bommel, Annelotte C M; Stowell, Caleb; Allison, Kim H.; Benn, Karen E.; Browne, John P.; Cooter, Rodney D.; Delaney, Geoff P.; Duhoux, Francois P.; Ganz, Patricia A.; Hancock, Patricia; Jagsi, Reshma; Knaul, Felicia M.; Knip, Anne M.; Koppert, Linetta B.; Kuerer, Henry M.; McLaughin, Sarah; Mureau, Marc A.M.; Partridge, Ann H.

In: JAMA Oncology, Vol. 3, No. 5, 2017, p. 677-685.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - A standard set of value-based patient-centered outcomes for breast cancer

T2 - The International Consortium for Health Outcomes Measurement (ICHOM) initiative

AU - Ong, Wee Loon

AU - Schouwenburg, Maartje G.

AU - Van Bommel, Annelotte C M

AU - Stowell, Caleb

AU - Allison, Kim H.

AU - Benn, Karen E.

AU - Browne, John P.

AU - Cooter, Rodney D.

AU - Delaney, Geoff P.

AU - Duhoux, Francois P.

AU - Ganz, Patricia A.

AU - Hancock, Patricia

AU - Jagsi, Reshma

AU - Knaul, Felicia M.

AU - Knip, Anne M.

AU - Koppert, Linetta B.

AU - Kuerer, Henry M.

AU - McLaughin, Sarah

AU - Mureau, Marc A.M.

AU - Partridge, Ann H.

PY - 2017

Y1 - 2017

N2 - A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The working group convened via 8 teleconferences and completed a follow-up survey after each meeting. A modified 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be included. Patient focus group meetings (8 early or metastatic BC patients) and online anonymized surveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input. The standard set encompasses survival and cancer control, and disutility of care (eg, acute treatment complications) outcomes, to be collected through administrative data and/or clinical records. A combination of multiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree of health outcomes. Selected case-mix factors were recommended to be collected at baseline. The ICHOM will endeavor to achieve wide buy-in of this set and facilitate its implementation in routine clinical practice in various settings and institutions worldwide.

AB - A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The working group convened via 8 teleconferences and completed a follow-up survey after each meeting. A modified 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be included. Patient focus group meetings (8 early or metastatic BC patients) and online anonymized surveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input. The standard set encompasses survival and cancer control, and disutility of care (eg, acute treatment complications) outcomes, to be collected through administrative data and/or clinical records. A combination of multiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree of health outcomes. Selected case-mix factors were recommended to be collected at baseline. The ICHOM will endeavor to achieve wide buy-in of this set and facilitate its implementation in routine clinical practice in various settings and institutions worldwide.

UR - http://www.scopus.com/inward/record.url?scp=85020123591&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2016.4851

DO - 10.1001/jamaoncol.2016.4851

M3 - Article

VL - 3

SP - 677

EP - 685

JO - JAMA Oncology

JF - JAMA Oncology

SN - 2374-2437

IS - 5

ER -